ALK-Abello AS - Strategy, SWOT and Corporate Finance Report
Summary
ALK-Abello AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
ALK-Abello AS. (ALK-Abello or 'the company') is a pharmaceutical company that develops and markets allergy treatment products in the form of injections, sublingual drops, and sublingual tablets. It also produces an adrenaline auto-injector for the treatment of severe allergic reactions (anaphylaxis) and also manufactures products used in the diagnosis of allergies. The company’s SLIT tablets cover the five common respiratory allergies, including grass, house dust mite, Japanese cedar, ragweed, and tree for children, adolescents, and adults. It has a business presence across Europe, North America, and other parts of the world. The company is headquartered in Horsholm, Denmark
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook